Draft Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors
The Food and Drug Administration made available a draft guidance entitled "Considerations When Transferring Clinical Investigation Oversight to Another IRB"
Action
Published Date
Agency
Contact Information
Bridget Foltz, 301-796-8340
Department
More Information
Pages
34958-34959
Program Area
Volume Number
77
